Orchid Pharma Limited (NSE:ORCHPHARMA)
India
· Delayed Price · Currency is INR 755.90
-0.15 (-0.02%)
Jul 7, 2025, 9:30 AM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 38.35 billion as of July 3, 2025. Its market cap has decreased by -29.19% in one year.
Market Cap
38.35B
Enterprise Value
38.30B
Revenue
9.22B
Ranking
n/a
PE Ratio
38.48
Stock Price
755.90
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 38.35B, an increase of 5,172.05%. That is a compound annual growth rate of 133.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 38.35B | -58.16% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,022.01B |
| Divi's Laboratories | 1,833.46B |
| Cipla | 1,222.30B |
| Apollo Hospitals Enterprise | 1,086.08B |
| Zydus Lifesciences | 1,007.24B |
| Mankind Pharma | 1,006.85B |
| Aurobindo Pharma | 691.91B |
| Fortis Healthcare | 609.29B |